| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glutathione | 10 | 2020 | 196 | 3.700 |
Why?
|
| Fluorescent Dyes | 6 | 2020 | 251 | 1.990 |
Why?
|
| Nuclear Receptor Coactivator 3 | 6 | 2021 | 257 | 1.740 |
Why?
|
| Molecular Imaging | 3 | 2018 | 61 | 1.460 |
Why?
|
| Oxidation-Reduction | 7 | 2021 | 435 | 1.030 |
Why?
|
| Sulfhydryl Compounds | 2 | 2015 | 55 | 0.870 |
Why?
|
| Polyethylene Glycols | 4 | 2013 | 245 | 0.830 |
Why?
|
| Nanoparticles | 4 | 2013 | 292 | 0.690 |
Why?
|
| Epoxy Compounds | 1 | 2021 | 19 | 0.690 |
Why?
|
| Flow Cytometry | 2 | 2020 | 768 | 0.690 |
Why?
|
| Macrolides | 1 | 2021 | 31 | 0.690 |
Why?
|
| Spliceosomes | 1 | 2021 | 49 | 0.670 |
Why?
|
| Intracellular Space | 3 | 2020 | 46 | 0.670 |
Why?
|
| Computer Systems | 1 | 2020 | 36 | 0.670 |
Why?
|
| HeLa Cells | 8 | 2018 | 694 | 0.630 |
Why?
|
| RNAi Therapeutics | 1 | 2018 | 17 | 0.580 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 666 | 0.580 |
Why?
|
| Bufanolides | 2 | 2015 | 13 | 0.580 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 296 | 0.570 |
Why?
|
| Azides | 3 | 2008 | 11 | 0.560 |
Why?
|
| Mustard Gas | 1 | 2017 | 3 | 0.550 |
Why?
|
| Molecular Probes | 1 | 2018 | 26 | 0.550 |
Why?
|
| Chemical Warfare Agents | 1 | 2017 | 6 | 0.550 |
Why?
|
| Cell Line, Tumor | 13 | 2021 | 3642 | 0.530 |
Why?
|
| Keratinocytes | 1 | 2017 | 74 | 0.530 |
Why?
|
| Fluorometry | 1 | 2017 | 25 | 0.530 |
Why?
|
| Cell Survival | 8 | 2020 | 850 | 0.530 |
Why?
|
| Biosensing Techniques | 1 | 2018 | 74 | 0.520 |
Why?
|
| Cell Proliferation | 7 | 2021 | 2459 | 0.520 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 176 | 0.500 |
Why?
|
| Hydrogen Sulfide | 1 | 2016 | 12 | 0.490 |
Why?
|
| Antioxidants | 2 | 2020 | 334 | 0.490 |
Why?
|
| Hydrazones | 1 | 2016 | 18 | 0.490 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 157 | 0.470 |
Why?
|
| Genetic Techniques | 1 | 2016 | 99 | 0.470 |
Why?
|
| Prodrugs | 1 | 2015 | 55 | 0.460 |
Why?
|
| Molecular Structure | 8 | 2018 | 320 | 0.460 |
Why?
|
| Benzimidazoles | 1 | 2016 | 156 | 0.450 |
Why?
|
| Epithelial Cells | 2 | 2016 | 895 | 0.420 |
Why?
|
| Nanotechnology | 2 | 2012 | 50 | 0.420 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2013 | 21 | 0.410 |
Why?
|
| Microsomes, Liver | 3 | 2020 | 96 | 0.390 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 728 | 0.380 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 1802 | 0.370 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2015 | 287 | 0.360 |
Why?
|
| Nanomedicine | 1 | 2011 | 27 | 0.350 |
Why?
|
| Nuclear Receptor Coactivator 1 | 3 | 2017 | 162 | 0.340 |
Why?
|
| Receptors, Transferrin | 1 | 2010 | 12 | 0.330 |
Why?
|
| Imines | 2 | 2015 | 10 | 0.300 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2020 | 363 | 0.300 |
Why?
|
| Biomarkers | 1 | 2018 | 3365 | 0.300 |
Why?
|
| Naphthalenes | 2 | 2016 | 39 | 0.300 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2010 | 163 | 0.290 |
Why?
|
| Methane | 1 | 2008 | 18 | 0.290 |
Why?
|
| Phenylacetates | 1 | 2008 | 27 | 0.290 |
Why?
|
| Ketones | 1 | 2008 | 27 | 0.280 |
Why?
|
| Microscopy, Confocal | 2 | 2020 | 362 | 0.280 |
Why?
|
| 3T3-L1 Cells | 2 | 2020 | 52 | 0.280 |
Why?
|
| Mice | 16 | 2021 | 18408 | 0.280 |
Why?
|
| Kinetics | 3 | 2017 | 1101 | 0.280 |
Why?
|
| Animals | 20 | 2021 | 34275 | 0.270 |
Why?
|
| Imides | 1 | 2007 | 1 | 0.270 |
Why?
|
| Glutaredoxins | 2 | 2019 | 30 | 0.270 |
Why?
|
| Benzene Derivatives | 1 | 2007 | 20 | 0.270 |
Why?
|
| Mice, SCID | 3 | 2018 | 579 | 0.260 |
Why?
|
| Reactive Oxygen Species | 3 | 2019 | 513 | 0.240 |
Why?
|
| Breast Neoplasms | 4 | 2021 | 2636 | 0.230 |
Why?
|
| Humans | 28 | 2021 | 130912 | 0.220 |
Why?
|
| Transfection | 3 | 2017 | 960 | 0.210 |
Why?
|
| Ultraviolet Rays | 2 | 2008 | 194 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 1975 | 0.200 |
Why?
|
| Mice, Nude | 3 | 2021 | 715 | 0.200 |
Why?
|
| Amides | 1 | 2003 | 90 | 0.200 |
Why?
|
| Cell Line | 5 | 2020 | 2596 | 0.180 |
Why?
|
| Thermodynamics | 2 | 2015 | 146 | 0.180 |
Why?
|
| Mice, Inbred BALB C | 2 | 2021 | 1018 | 0.180 |
Why?
|
| Plant Physiological Phenomena | 1 | 2021 | 7 | 0.170 |
Why?
|
| Reference Standards | 2 | 2020 | 231 | 0.170 |
Why?
|
| Sulfonamides | 1 | 2003 | 290 | 0.170 |
Why?
|
| Carboxy-Lyases | 1 | 2021 | 14 | 0.170 |
Why?
|
| Myelin and Lymphocyte-Associated Proteolipid Proteins | 1 | 2021 | 2 | 0.170 |
Why?
|
| Oxalates | 1 | 2021 | 22 | 0.170 |
Why?
|
| Stereoisomerism | 1 | 2021 | 116 | 0.170 |
Why?
|
| Antigen Presentation | 1 | 2021 | 117 | 0.170 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2020 | 22 | 0.170 |
Why?
|
| Cell Size | 1 | 2020 | 81 | 0.170 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2020 | 33 | 0.170 |
Why?
|
| Calibration | 1 | 2020 | 96 | 0.170 |
Why?
|
| Models, Molecular | 3 | 2021 | 1084 | 0.170 |
Why?
|
| Tumor Escape | 1 | 2021 | 63 | 0.160 |
Why?
|
| Neurogenic Inflammation | 1 | 2020 | 4 | 0.160 |
Why?
|
| Signal Transduction | 5 | 2021 | 4645 | 0.160 |
Why?
|
| Stem Cell Niche | 1 | 2020 | 57 | 0.160 |
Why?
|
| Arabidopsis | 1 | 2021 | 89 | 0.160 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2019 | 128 | 0.160 |
Why?
|
| Staining and Labeling | 1 | 2020 | 170 | 0.160 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2020 | 44 | 0.160 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2021 | 166 | 0.160 |
Why?
|
| Transcription, Genetic | 4 | 2018 | 1396 | 0.160 |
Why?
|
| DNA | 2 | 2015 | 1444 | 0.160 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 208 | 0.150 |
Why?
|
| Oxidative Stress | 3 | 2020 | 798 | 0.150 |
Why?
|
| Haploidy | 1 | 2019 | 19 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 999 | 0.150 |
Why?
|
| Biological Products | 1 | 2021 | 144 | 0.150 |
Why?
|
| Mice, Inbred ICR | 2 | 2016 | 151 | 0.150 |
Why?
|
| Microglia | 1 | 2020 | 133 | 0.140 |
Why?
|
| Cardiomegaly | 1 | 2019 | 120 | 0.140 |
Why?
|
| RNA Polymerase II | 1 | 2018 | 91 | 0.140 |
Why?
|
| Multiple Myeloma | 1 | 2021 | 216 | 0.140 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 2008 | 41 | 0.140 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 565 | 0.140 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 402 | 0.140 |
Why?
|
| Tumor Burden | 1 | 2018 | 238 | 0.140 |
Why?
|
| NADP | 1 | 2017 | 53 | 0.140 |
Why?
|
| NAD | 1 | 2017 | 50 | 0.140 |
Why?
|
| Drug Resistance, Multiple | 1 | 2017 | 56 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 588 | 0.130 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2020 | 237 | 0.130 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2018 | 92 | 0.130 |
Why?
|
| Single-Cell Analysis | 2 | 2020 | 368 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2018 | 364 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 644 | 0.130 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 674 | 0.120 |
Why?
|
| Protein Conformation | 2 | 2021 | 807 | 0.120 |
Why?
|
| Receptors, Melatonin | 1 | 2016 | 2 | 0.120 |
Why?
|
| Repressor Proteins | 1 | 2021 | 778 | 0.120 |
Why?
|
| Multiple Sclerosis | 1 | 2020 | 391 | 0.120 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2020 | 551 | 0.120 |
Why?
|
| Acetamides | 1 | 2016 | 44 | 0.120 |
Why?
|
| Mannose | 1 | 2015 | 22 | 0.120 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 819 | 0.120 |
Why?
|
| Serum Albumin, Bovine | 2 | 2013 | 53 | 0.120 |
Why?
|
| Longevity | 1 | 2017 | 176 | 0.120 |
Why?
|
| Aldehydes | 1 | 2015 | 28 | 0.120 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2016 | 112 | 0.120 |
Why?
|
| Caenorhabditis elegans | 1 | 2017 | 250 | 0.120 |
Why?
|
| Lactation | 1 | 2016 | 196 | 0.110 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2015 | 50 | 0.110 |
Why?
|
| Transcription Factor AP-1 | 1 | 2015 | 113 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 95 | 0.110 |
Why?
|
| Cell Movement | 1 | 2018 | 874 | 0.110 |
Why?
|
| Ligands | 2 | 2020 | 485 | 0.110 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 90 | 0.110 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 133 | 0.110 |
Why?
|
| Estrogen Receptor alpha | 1 | 2018 | 433 | 0.110 |
Why?
|
| Female | 12 | 2021 | 70740 | 0.110 |
Why?
|
| Polymers | 1 | 2015 | 113 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 1 | 2017 | 330 | 0.110 |
Why?
|
| Plasmids | 1 | 2015 | 455 | 0.110 |
Why?
|
| Oxygen | 1 | 2018 | 555 | 0.110 |
Why?
|
| Aging | 2 | 2019 | 1257 | 0.110 |
Why?
|
| Quinazolines | 1 | 2015 | 181 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 237 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 353 | 0.100 |
Why?
|
| Esterification | 1 | 2013 | 13 | 0.100 |
Why?
|
| Mammary Glands, Animal | 1 | 2016 | 446 | 0.100 |
Why?
|
| Oligonucleotides | 1 | 2013 | 96 | 0.100 |
Why?
|
| Jurkat Cells | 1 | 2013 | 84 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 339 | 0.100 |
Why?
|
| Apoptosis | 3 | 2021 | 1852 | 0.100 |
Why?
|
| Folic Acid | 1 | 2015 | 285 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 1821 | 0.100 |
Why?
|
| RNA | 2 | 2013 | 531 | 0.100 |
Why?
|
| Cattle | 2 | 2012 | 540 | 0.100 |
Why?
|
| Microtechnology | 1 | 2012 | 6 | 0.090 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2012 | 25 | 0.090 |
Why?
|
| Receptors, Estrogen | 1 | 2015 | 727 | 0.090 |
Why?
|
| MCF-7 Cells | 3 | 2018 | 210 | 0.090 |
Why?
|
| Delayed-Action Preparations | 1 | 2012 | 119 | 0.090 |
Why?
|
| Escherichia coli | 1 | 2017 | 981 | 0.090 |
Why?
|
| Drug Carriers | 1 | 2012 | 117 | 0.090 |
Why?
|
| Cells | 1 | 2011 | 20 | 0.090 |
Why?
|
| Time Factors | 4 | 2012 | 6275 | 0.090 |
Why?
|
| Macrophages | 1 | 2015 | 663 | 0.090 |
Why?
|
| Photochemistry | 2 | 2008 | 21 | 0.090 |
Why?
|
| Endocytosis | 1 | 2011 | 130 | 0.080 |
Why?
|
| Tissue Distribution | 1 | 2011 | 365 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 606 | 0.080 |
Why?
|
| Drug Design | 1 | 2011 | 165 | 0.080 |
Why?
|
| Biological Transport | 1 | 2010 | 332 | 0.080 |
Why?
|
| Lipids | 1 | 2013 | 566 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2010 | 429 | 0.080 |
Why?
|
| Metabolomics | 3 | 2020 | 488 | 0.080 |
Why?
|
| Immunohistochemistry | 3 | 2018 | 1614 | 0.080 |
Why?
|
| Mice, Knockout | 4 | 2020 | 3850 | 0.070 |
Why?
|
| Diazonium Compounds | 1 | 2008 | 3 | 0.070 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2008 | 23 | 0.070 |
Why?
|
| Models, Chemical | 1 | 2008 | 81 | 0.070 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2008 | 22 | 0.070 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2021 | 193 | 0.070 |
Why?
|
| Spectrophotometry | 1 | 2007 | 55 | 0.070 |
Why?
|
| Azepines | 1 | 2008 | 62 | 0.070 |
Why?
|
| Quantum Theory | 1 | 2007 | 19 | 0.070 |
Why?
|
| Ions | 1 | 2007 | 25 | 0.070 |
Why?
|
| Translocation, Genetic | 2 | 2021 | 350 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2015 | 1611 | 0.070 |
Why?
|
| Heart Failure | 1 | 2019 | 2341 | 0.060 |
Why?
|
| Protein Binding | 2 | 2020 | 1705 | 0.060 |
Why?
|
| Isoenzymes | 2 | 2016 | 216 | 0.060 |
Why?
|
| Molecular Conformation | 1 | 2003 | 98 | 0.050 |
Why?
|
| DNA, Superhelical | 1 | 2003 | 23 | 0.050 |
Why?
|
| Gene Silencing | 2 | 2015 | 228 | 0.050 |
Why?
|
| Particle Size | 2 | 2013 | 141 | 0.050 |
Why?
|
| Distamycins | 1 | 2002 | 1 | 0.050 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2002 | 61 | 0.040 |
Why?
|
| Plant Development | 1 | 2021 | 5 | 0.040 |
Why?
|
| Proteasome Inhibitors | 1 | 2021 | 57 | 0.040 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2021 | 62 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2021 | 55 | 0.040 |
Why?
|
| Bortezomib | 1 | 2021 | 73 | 0.040 |
Why?
|
| Organic Chemistry Phenomena | 1 | 2020 | 3 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 4737 | 0.040 |
Why?
|
| Atomoxetine Hydrochloride | 1 | 2020 | 16 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2021 | 96 | 0.040 |
Why?
|
| Acrylamides | 1 | 2020 | 25 | 0.040 |
Why?
|
| Half-Life | 1 | 2020 | 151 | 0.040 |
Why?
|
| Isoxazoles | 1 | 2020 | 32 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2021 | 334 | 0.040 |
Why?
|
| Norepinephrine | 1 | 2020 | 155 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 114 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2020 | 135 | 0.040 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 138 | 0.040 |
Why?
|
| Protein Transport | 1 | 2021 | 359 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2021 | 586 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2021 | 785 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2020 | 125 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2020 | 365 | 0.040 |
Why?
|
| Proteolysis | 1 | 2020 | 189 | 0.040 |
Why?
|
| Ribonucleoprotein, U4-U6 Small Nuclear | 1 | 2019 | 1 | 0.040 |
Why?
|
| N-Terminal Acetyltransferase C | 1 | 2019 | 2 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2020 | 117 | 0.040 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2019 | 35 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2021 | 306 | 0.040 |
Why?
|
| Immunoprecipitation | 1 | 2018 | 190 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2018 | 291 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 455 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 373 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2017 | 33 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 62 | 0.030 |
Why?
|
| Histones | 1 | 2021 | 515 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2020 | 409 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2021 | 1523 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2019 | 246 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 419 | 0.030 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2016 | 16 | 0.030 |
Why?
|
| Recurrence | 1 | 2021 | 1473 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 2560 | 0.030 |
Why?
|
| Mitochondrial Dynamics | 1 | 2017 | 53 | 0.030 |
Why?
|
| Male | 5 | 2021 | 64819 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 415 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2016 | 110 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2018 | 513 | 0.030 |
Why?
|
| Pregnancy, Animal | 1 | 2016 | 69 | 0.030 |
Why?
|
| RANK Ligand | 1 | 2016 | 52 | 0.030 |
Why?
|
| Milk Proteins | 1 | 2016 | 85 | 0.030 |
Why?
|
| Semicarbazides | 1 | 2016 | 3 | 0.030 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2017 | 104 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2017 | 142 | 0.030 |
Why?
|
| Biotransformation | 1 | 2016 | 53 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 632 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2002 | 811 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2017 | 135 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2017 | 2430 | 0.030 |
Why?
|
| Metabolic Detoxication, Phase I | 1 | 2015 | 9 | 0.030 |
Why?
|
| Cytochrome P-450 CYP3A Inhibitors | 1 | 2015 | 10 | 0.030 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2015 | 14 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 2017 | 230 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 261 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2015 | 54 | 0.030 |
Why?
|
| Models, Animal | 1 | 2017 | 459 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 232 | 0.030 |
Why?
|
| Microcirculation | 1 | 2015 | 111 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2017 | 802 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 383 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2016 | 1018 | 0.030 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2015 | 135 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 530 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2016 | 442 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2017 | 772 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 3457 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2015 | 237 | 0.030 |
Why?
|
| Proteomics | 1 | 2018 | 597 | 0.030 |
Why?
|
| Calorimetry | 1 | 2013 | 63 | 0.030 |
Why?
|
| Bioengineering | 1 | 2013 | 15 | 0.030 |
Why?
|
| Digoxin | 1 | 2014 | 38 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2015 | 294 | 0.030 |
Why?
|
| Phosphatidylethanolamines | 1 | 2013 | 23 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 136 | 0.030 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2013 | 37 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 665 | 0.030 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2013 | 49 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2018 | 1021 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2019 | 2965 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2016 | 683 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 703 | 0.020 |
Why?
|
| Feces | 1 | 2016 | 724 | 0.020 |
Why?
|
| Disulfides | 1 | 2012 | 79 | 0.020 |
Why?
|
| Solubility | 1 | 2012 | 120 | 0.020 |
Why?
|
| Vero Cells | 1 | 2012 | 114 | 0.020 |
Why?
|
| Luciferases | 1 | 2012 | 127 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 1000 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 1311 | 0.020 |
Why?
|
| Genome, Human | 1 | 2019 | 1331 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 1217 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2013 | 343 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2012 | 252 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 2575 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 1834 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 6862 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 4680 | 0.020 |
Why?
|
| Disease Progression | 1 | 2015 | 2191 | 0.020 |
Why?
|
| Acetonitriles | 1 | 2008 | 3 | 0.020 |
Why?
|
| Photolysis | 1 | 2008 | 10 | 0.020 |
Why?
|
| Solutions | 1 | 2008 | 53 | 0.020 |
Why?
|
| Dimerization | 1 | 2008 | 139 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2344 | 0.020 |
Why?
|
| Water | 1 | 2008 | 188 | 0.020 |
Why?
|
| Mutation | 1 | 2020 | 6143 | 0.020 |
Why?
|
| Pregnancy | 1 | 2016 | 7551 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 21134 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 28730 | 0.010 |
Why?
|
| Pyrroles | 1 | 2002 | 185 | 0.010 |
Why?
|
| Imidazoles | 1 | 2002 | 220 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 31533 | 0.010 |
Why?
|